



 This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 
3.0). Copyright © 2014 Shahid Beheshti University of Medical Sciences. All rights reserved. Downloaded from: www.jemerg.com 
 




QT Interval in Pregnant and Non-pregnant Women 
 
Majid Zamani1, Mehrdad Esmailian1, Zahra Yoosefian2* 
1. Department of Emergency Medicine, Isfahan University of Medical Sciences, Isfahan, Iran  
2. Department of Emergency Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 
Abstract 
Introduction: Prolongation of QT interval might result in dangerous cardiac arrhythmias, including Torsades de 
Pointes (TdP), consequently leading to syncope or death. A limited number of studies carried out in this respect 
to date have shown that QT interval might increase during pregnancy. On the other hand, it has been shown that 
each pregnancy might result in an increase in the risk of cardiac accidents in patients with long QT interval. 
Therefore, the present study was undertaken to compare QT intervals in pregnant and non-pregnant women. 
Methods: Pregnant women group consisted of 40 women in the second and third trimesters of pregnancy and the 
non-pregnant control group consisted of healthy women 18-35 years of age. All the patients underwent standard 
12-lead electrocardiogram (ECG). The QT interval was measured for each patient at lead II. The mean corrected 
QT interval (QTc) and QT dispersions (QTd) were compared between the two groups. Results: Mean heart rates 
in the pregnant and non-pregnant groups were 98.55±14.09 and 72.53±13.17 beats/minutes (P<0.001). QTd and 
QTc means were in the normal range in both groups; however, these variables were 49.50±12.80 and 
43.03±18.47 milliseconds in the pregnant group and 39.5±9.59 and 40.38±17.20 milliseconds in the control 
group, respectively (P<0.001). Conclusion: The QT interval was longer in pregnant women compared to non-
pregnant women; however, it was in the normal range in both groups. Therefore, it is important to monitor and 
manage risk factors involved in prolongation of QT interval and prevent concurrence of these factors with preg-
nancy. 
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ong QT syndrome, which is characterized by an 
increase in QT interval on electrocardiogram 
(ECG), makes patients susceptible to cardiac ar-
rhythmias, including Torsades de Pointes (TdP), fol-
lowed by repeated syncope episodes and even sudden 
death (1). The syndrome has two forms: hereditary and 
acquired. The hereditary form is a familial genetic 
canalopathy (2) and the acquired form is a reversible 
condition induced by an environmental factor, usually a 
drug from various groups, including some antihista-
mines, antibiotics, antipsychotic drugs or gastrointesti-
nal prokinetics (3). In addition, several risk factors have 
been identified involved in prolongation of QT interval 
and the related arrhythmias, which include hypokale-
mia, hypomagnesemia, hypothyroidism, and hemodial-
ysis. Concurrence of these factors can increase the risk 
of ventricular arrhythmia and the subsequent accidents. 
Therefore, in patients with these risk factors care 
should be exercised in concomitant prescription of the 
drugs mentioned above (1). Corrected QT (QTc) and QT 
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dispersion (QTd) indexes are used to evaluate the QT 
index; QTc is used to correspond the QT interval with 
the heart rate and both in fact show various dimensions 
of ventricular repolarization (4). Various physiologic 
changes occur during pregnancy, including changes in 
the cardiovascular system. Cardiac arrhythmias are not 
uncommon during pregnancy and might create differ-
ent problems for the mother and the fetus (5). On the 
other hand, female gender is considered as an inde-
pendent risk factor for long QT syndrome; in this con-
text, QT interval is almost 10% longer in adult females. 
Various studies have introduced sex hormones (both 
male and female) as a factor effective on the QT interval 
(6-9). Considering hormonal changes occurring during 
the pregnancy, it is possible for the QT interval to be 
affected. Insufficient data is available in relation to the 
effect of pregnancy on QT interval. Although the inter-
val is expected to be decreased in pregnancy due to 
tachycardia, some studies have shown that the interval 
increases in pregnant women (10). Lechmanova et al. 
explained the reasons for an increase in QT and QTd 
intervals in pregnancy as follows: enlarged abdominal 
organs, hormonal and sympathetic changes, and finally 
an increase in the impedance of tissues located between 
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cumulation of water and sodium during pregnancy (10).  
On the other hand, studies have shown that patients 
with long QT syndrome (LQTs) run a higher risk of de-
veloping TdP immediately after pregnancy (11-13). 
Based on above-mentioned, the present study was de-
signed to evaluate and compare the QT interval in preg-
nant and non-pregnant women to assess the effect of 
pregnancy on QT interval. 
Methods: 
Study design and setting  
This prospective cohort study was carried out from 
April 2011 to December 2012 in Shahid Behesthi Hospi-
tal, Shiraz, Iran. The protocol of the study was approved 
by Shiraz University of Medical Sciences and the Ethics 
Committee of the same university. Informed consent 
forms were taken from all the subjects.   
Participants 
The subjects were randomly selected from women re-
ferring to the clinic for routine pregnancy examinations. 
In addition, the control group subjects were randomly 
selected from the individuals accompanying patients 
referring to the clinic. 40 women in the second and 
third trimesters of pregnancy (over 13 weeks of gesta-
tional age according to a sonographic examination of 
the first trimester) were included in the pregnant wom-
en group and 40 non-pregnant women who were in 
their fertile years were included in the control group. 
Inclusion criteria of the study were an age range of 18-
35 years, interest in and ability to take part in the study, 
an interval of at least one year between the present 
pregnancy and the previous one. In addition, exclusion 
criteria were the presence of any arrhythmia in ECG, 
use of any medication influencing QT interval, affliction 
with any cardiac and renal disease. 
Data collection  
Serial evaluation of ECGs was carried out and the cardi-
ac enzymes, including troponin I and cardiac isoen-
zymes creatine kinase, were checked. Cardiac enzymes 
were evaluated every six hours up to three times. In 
addition, ECGs were evaluated whenever chest pain 
recurred. The age, gender, marital status, occupation, 
living place and phone number of patients were ques-
tioned and registered. They were asked to refer to the 
exercise test unit of Imam Hossein Hospital during one 
week after discharging. When the patients returned to 
the exercise test unit, they were asked about the inci-
dence of cardiac symptoms and signs, recurrence of 
chest pain or referring to the treatment center again. 
After the exercise test, the results were collected and 
patients with positive test underwent angiography. 
Then, the patients were followed for a month. At the 
time of discharge, the patients or their relatives re-
ceived instructions in relation to the symptoms and 
signs of cardiac diseases. 
Endpoints 
History of medications used and cardiac diseases, the 
patients’ demographic data, and the gestational ages 
were recorded. All the subjects were questioned in rela-
tion to the occurrence of any of the symptoms and signs 
of syncope, palpitation, vertigo, angina, and asthma (a 
collection of symptoms and signs, which might have a 
cardiac origin) in the six-month period before taking 
part in the study for the control group and at the begin-
ning of pregnancy for the pregnant group. A standard 
12-lead ECG (paper speed of 25 mm/s and a current of 
0.5 mv/cm) was recorded from each subject. The QT 
interval, from the beginning of Q to the end of T, was 
measured and recorded. Then Bazett’s formula, 
QTc=QT/√RR, was used to match the interval with the 
heart rate. QT dispersion (QTd) was also calculated as 
the difference between the maximum and minimum QT 
intervals in a 12-lead ECG (4). The ECGs were also used 
to determine the presence or absence of any arrhyth-
mia and the axes of QRS and P waves. 
Statistical analysis 
Data were collected, sorted and analyzed with SPSS 18. 
Independent t-test was used to compare continuous 
data between the two groups. Chi-squared test was 
used to compare qualitative data and frequencies of 
symptoms and signs between the two groups. Descrip-
tive data were presented as means ± SD. Statistical sig-
nificance was defined at P<0.05.  
Results: 
Eighty subjects participated in the present study: 40 in 
the pregnant women group and 40 in the control group, 
with mean ages of 29±2.8 and 28±3.2 years, respective-
ly. The mean gestational age of pregnant women was 
29.21±7.40 weeks (19-42). Sixteen patients (41%) had 
their first pregnancy, 134 (33.3%) second pregnancy, 
eight (20.5%) third pregnancy, one (2.6%) fourth preg-
nancy and one (2.6%) fifth pregnancy. QRS and P waves 
of all the subjects were in the normal range, with no 
significant differences between the two groups 
(P>0.05). QTc and QTd were higher in the pregnant 
group versus the control (0.001). It should be pointed 
out that the means of these two variables were in the 
normal range. Table 1 presents the details of compari-
sons of QTc, QTd, and heart rates between the two 
groups. In general, there were no significant differences 
between the means of QTc and QTd between pregnant 
women in their second trimesters and those in their 
third trimesters (P>0.05) (Table 2). 
Discussion:  
The results of present study showed a longer QT inter-
val in pregnant women versus non-pregnant. However, 
QTd and QTc means were in the normal range in both 
groups. A research in available library and electronic 
sources showed only a limited number of studies with 
similar themes. There are some studies on the effect of 
pregnancy on patients with LQTS (12-16). Lechmanova 
et al. (2002) evaluated QT interval and T-loop morphol-
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pared 37 healthy pregnant women with gestational ag-
es of 36-40 weeks with 18 healthy non-pregnant wom-
en. All the subjects underwent electrocardiography and 
vectorcardiography evaluations. Finally, it was conclud-
ed that QTc and QTd were significantly higher in preg-
nant women compared to the control group (10), con-
sistent with the results of the present study. Isezuo et 
al. (2004) evaluated and compared QT intervals be-
tween pregnant women with and without eclampsia. 
They did not make comparisons with the control non-
pregnant women. In general, the mean QTc in the group 
with eclampsia (47.0 milliseconds) and the group with-
out it (43.6 milliseconds) was higher than that in the 
present study (41.75 milliseconds) (17). Seth et al. con-
cluded that pregnant women with a previous definitive 
diagnosis of LQTS run a lower risk of cardiac accidents 
during pregnancy, including syncope and sudden death 
due to cardiac arrest. However, during the first nine 
months after delivery, the risk of cardiac accidents, es-
pecially life-threatening accidents, increases. After this 
period, the risk level returns to the baseline before 
pregnancy (13). Rashba et al. (1998) reported similar 
results (12). None of the two studies above evaluated 
the question whether the QT interval changes during 
pregnancy or after it. Seth et al. described the reason for 
a decrease in cardiac accidents due to LQTS during 
pregnancy and an increase in such accidents after preg-
nancy as follows: Pregnancy results in an increase in 
the referral of women to health and treatment centers, 
which might lead to prevention of cardiac accidents. On 
the other hand, although the QT intervals were not dif-
ferent between nulliparous women and those with pre-
vious pregnancies, women with no history of delivery 
before the age of 15 had experienced more cardiac ac-
cidents and received more treatments with β-blockers, 
all of which might have prompted them to refrain from 
becoming pregnant (13).  
During the period after delivery, hemodynamic changes 
occur, which might be related to an increase in ar-
rhythmias. For example, cardiac output, which increas-
es significantly during pregnancy, decreases suddenly. 
Rashba et al. proposed the hypothesis that an increase 
in cardiac accidents in patients with LQTS after delivery 
might be attributed to a change in adrenergic activity. 
They also reported that an increase in heart rate during 
pregnancy could have a protective effect in patients 
with LQTS, who might have a longer QT interval at low-
er heart rates; after delivery, this rate returns to the 
baseline. Therefore, this protective role is negated, in-
creasing the odds of QT interval Prolongation, and inci-
dence of arrhythmias (12). Some other studies have 
shown that other factors such as an increase in stress, 
fatigue, insomnia, and other environmental factors are 
effective in increasing the risk of cardiac accidents due 
to LQTS during pregnancy. Another opinion about the 
possible cause of the relationship between pregnancy 
and a change in QT interval is the relation between sex 
hormones and ventricular repolarization. Several stud-
ies have evaluated this relationship but no definitive 
results have been achieved. One of the risk is that both 
exogenous and endogenous sex hormones can influence 
QT interval (6, 7, 18, 19). In general, during sexual mat-
uration the QT interval is shortened about 20 millisec-
onds in males; however, it does not undergo any chang-
es in females. In fact, the QT interval is not significantly 
different between the two sexes and the shortening 
during sexual maturation is responsible for the differ-
ence (20). Some studies have suggested that testos-
terone is related to shorter repolarization in men (21). 
Based on a report by Naagawa et al. the QT interval in 
the luteal phase is shorter than that in the follicular 
phase, which might be attributed to the effect of proges-
terone (18). Therefore, it is possible that the QT interval 
is influenced by hormonal changes due to pregnancy. 
However, some studies have shown that hormonal 
changes in pregnancy decrease the risk of TdP in pa-
Table 1: Comparisons of QTc, QTd, and heart rates between the pregnant and non-pregnant groups  
Variables Groups Minimum Maximum Mean±SD P 
Heart rate 
Pregnant 68 130 98.55±14.09 
<0.001 
Control 51 118 72.53±13.17 
QTd 
Pregnant 30 80 49.50±12.80 
<0.001 
Control 20 60 39.50±9.59 
QTc 
Pregnant 380 460 430.30±18.47 
<0.001 
Control 370 440 403.80±17.20 
 
Table 2: Comparison of QTc and QTd between the second and third trimesters  
P Mean ± SD Number of patients Trimester Variable 
0.726 
431.3±15.98 17 Second 
QTc 
429.1±20.43 23 Third 
0.915 
48.67±11.80 17 Second 
QTd 
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tients with LTQS (13). One of the limitations of the pre-
sent study was the unavailability of the patients’ previ-
ous ECGs for making comparisons. On the other hand, 
there were limitations in the selection of controls; selec-
tion of controls from first-degree relatives was more 
logical and not possible. Further studies are necessary 
to confirm or refute the results of the present study.  
Conclusion: 
The QT interval in pregnant women was in the normal 
range but longer compared to non-pregnant women. 
Therefore, other factors that might be involved in pro-
longation of the QT interval should be taken into ac-
count and care should be exercised to prevent their 
concurrence with pregnancy as far as possible. 
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